Interest by the worldwide agricultural community in using viable microorganisms or microbial byproducts to control insect pests has increased rapidly. A primary concern is the potential risk to human health from accidental long-term inhalation of the agent during field application. It is recognized that most microbial pesticides will be avirulent or minimally pathogenic to vertebrates. However, Microsporidium, which have classically been considered non-human pathogens, have recently been implicated in infection of humans with compromised immune systems (5, 13) . Despite the minimal virulence of the majority of these agents, some method must exist to test these microbes for possible effects arising from inapparent infections, in order to adequately predict the possible health hazards of these agents. For this reason, the potential for infectivity or toxicity by the pulmonary route should be evaluated. This can be accomplished by administration of the agent either in aerosol form or via intranasal (i.n.) or intratracheal (i.t.) instillation to experimental animals.
The present Environmental Protection Agency guidelines specify testing for pulmonary toxicity and infectivity by inhalation with microbial aerosols (17) . Inhalation exposures are not easily performed in most laboratories because of the specialized equipment used for generating and monitoring microbial aerosols. Considerable cost is incurred in the design and construction of appropriate inhalation chambers and cages requiring airlocks, negative pressure, and adequate filtration systems. Furthermore, it is often technically difficult and costly to generate and deliver reproducible homogenous aerosols of viable microorganisms to the deep lung. Also, aerosolization of large microorganisms such as protozoa and fungal hyphae virtually insures nonviability of the administered organisms due to the shear forces necessary to generate an aerosol of respirable size. Current studies in our laboratories are attempting to determine the most appropriate method of pulmonary delivery for larger microorganisms.
The objective of these studies was to develop a simplified methodology for testing toxicity and virulence of microbial pesticides with the goal of increasing the sensitivity and the cost effectiveness over the present microbial pesticide acute * Corresponding author. inhalation infectivity tests (17) . These studies were designed using a bacterium and virus of known virulence in mice to compare aerosol challenge with i.n. or i.t. inoculation. In this report the 50% lethal dose (LD50) for male and female CD1 mice infected with Streptococcus zooepidemicus or influenza virus by the three challenge routes (i.n., i.t., and aerosol) is reported. (1, 8, 11) .
In organ clearance studies, organs were removed aseptically, placed on ice in 2 ml of 1% tryptose broth, and homogenized with a sterile PT10 sawtooth probe generator with a PT 10-35 homogenizer (Brinkmann Instruments, Waterbury, N.Y. Female mice only were used in organ clearance studies, as Influenza virus-challenged mice died soonest after i.n. the preliminary studies indicated no significant differences in lation. The dose effect for both S. zooepidemicus and mortality due to sex. The clearance of 1 LD50 of S. zooepinza virus challenge was highly significant (P < 0.0001) demicus from selected organs of mice infected by the three n. and i.t. inoculation, indicating that the higher the exposure routes is shown in Fig. 4 dence rate), while only 25% of the mice termed nonproliferators (see below) had bacteria in organs other than the lung.
After i.t. inoculation, only 0.7 and 0.04% of the initial dose remained 2 and 5 h postinfection, respectively. Increasing numbers of bacteria were observed thereafter. Small numbers of streptococci were observed in the liver of one mouse 24 h postinfection, with considerable numbers observed in nonpulmonary tissues 96, 120, and 144 h (data not shown) after infection.
Of the eight aerosol-infected mice sampled at each time point, one mouse sacrificed 72 h postinfection and three mice at 96 h postinfection had many more bacteria present than did their counterparts and were termed "proliferators" versus "nonproliferators" for those mice with lower numbers of bacteria. Nonproliferation was defined as a pulmonary bacterial concentration less than the mean bacterial concentration of mice sacrificed at time 0; bacterial proliferation was defined as a concentration exceeding the mean time 0 concentration (14) . Streptococcal proliferation was observed in the lungs of eight, three, and five mice inoculated i.n. after 96, 120, and 144 h, respectively. Streptococcal proliferation was observed in the lungs of two, eight, six, and six mice infected i.t. after 24, 96, 120, and 144 h, respectively.
The clearance of a calculated LD50 of influenza virus from selected organs of female mice infected by the three exposure routes is shown in Fig. 5 . Each time point represents the mean data from five mice per exposure route. Few viruses were isolated immediately after challenge. Some extrapulmonary virus was observed in i.n.-and i.t.-challenged mice. These initial viral counts correlated inversely with subsequent mortality (Fig. 5B) , as highest counts were observed in i.t.-inoculated mice, which had the lowest observed mortality, as opposed to aerosol-challenged mice, which had the lowest initial pulmonary titer but the highest mortality rate. Viral titers rose rapidly and remained elevated in the organs tested throughout the 8-day assay period. High viral titers were observed 24 to 144 h postinfection in both i.n.-and aerosol-challenged mice before they began to decrease. Viral titers remained high 24 to 168 h postinfection in i.t.-challenged mice before decreasing. DISCUSSION Animal models of clearance of inhaled bacterial aerosols from pulmonary tissue have been used for over 20 years as a sensitive method of assessing air pollutant toxicity to host pulmonary defenses (6, 9) . Bacterial aerosols have been used because deposition of inhaled bacteria is regarded as a noninvasive method of infection which mimics actual exposure. However, natural infection initiated by inhalation in a 10-to 30-min period of >104 particles, 1 to 2 pLm in size, containing viable bacteria is probably the exception rather than the rule! Other factors detracting from aerosol exposures include cost and technical difficulty. The problems of reproducibility are demonstrated in these studies by the relatively poor correlation of spray suspension optical density, calculated number of bacteria aerosolized, numbers in impinger samples, and actual numbers of inhaled viable bacteria recovered. These differences, although large, are common and reflect the increased sampling errors inherent in work with aerosols of viable microorganisms. Experience in this and previous studies has shown that reproduction of previous aerosol exposures is very difficult as bacterial concentration, nebulizer spray bar size, and chamber temperature, humidity, and airflow can individually or collectively significantly alter bacterial viability and pulmonary deposition. Decreased bacterial counts were found in lungs of mice challenged by aerosol inhalation for up to 48 h postinfection, whereas mice challenged i.t. and i.n. rapidly cleared the initial inoculum but had increasing numbers from 24 h postinfection. Explanation for these altered clearance patterns may reside in the type of inoculum administered. Because of the small particle size of the S. zooepidemicus aerosol (99.6% of the particles were less than 1.3 ,um in size, as determined with a nonbacterial liquid aerosol in the same nebulizer and exposure system used for these studies; unpublished data) it may be assumed that the majority of inhaled particles contained only one or two viable bacteria per particle. However, i.t. or i.n. instillation of streptococci would allow chains of bacteria of various lengths to be administered directly into the deep lung. Because aerosolized streptococci were generally evenly dispersed single organisms, alveolar macrophages were apparently initially able to handle the infection. The occasional bacterium that escaped early phagocytosis appeared to be phagocytized later before it had adequate time to replicate beyond the ability of the alveolar macrophages to cope. In contrast, streptococci delivered i.t. or i.n., although rapidly cleared initially, appeared to quickly overwhelm the resident pulmonary defenses perhaps because the occasional chain of bacteria that evaded killing contained enough organisms so that their growth rate enabled them to overwhelm the pulmonary defenses. Disruption of bacterial chains before administration might cause streptococcal pathogenesis following i.t. or i.n. inoculation to mimic aerosol infection more closely. The fact that time to death was increased in these mice may indicate that the quick overwhelming of normal pulmonary defenses resulted in early influx of polymorphonuclear leukocytes as a second line of defense before significant extrapulmonary dissemination had occurred. Apparently the large number of disseminated infection foci following aerosol challenge resulted in widespread pulmonary damage from infection or a pulmonary burden too great for even polymorphonuclear leukocytes to hold in check, resulting in the early deaths of these mice.
Increased virulence of i.n.-versus aerosol-administered bacteria has also been reported for Klebsiella pneumoniae (3) and Nocardia asteroides (2) . The authors of these studies speculated that the difference might be attributable to different deposition sites (3) or bacterial injury during aerosolization, introduction of clumps of bacteria by i.n. administration, or an effect of liquid suspension medium or anesthetic (2) . It is unlikely that increased virulence was induced by the anesthetic because studies with streptococci have failed to demonstrate enhanced susceptibility to infection following various anesthesia treatments (10 after aerosol challenge is puzzling. It is unclear whether this pattern of low-level bacterial septicemia is due to wholebody exposure with additional bacterial challenge from grooming and swallowing of bacteria, to penetration of mucus membranes, or to the increased time period between initial inoculation and sacrifice (40 min versus 5 min for i.t. and i.n.), or is an unavoidable consequence of whole-body exposure with a micrometer-sized bacterial aerosol.
The pattern of bacterial multiplication and pathogenesis, surprisingly, is different for mice challenged i.n. or i.t., despite the similarity of the regression curves correlating inoculated dose and mortality. The reason for these subtle differences is not known.
In a similar study, mice exposed to viable aerosols of group C streptococci causing an ultimate 36% mortality rate had clearance rates over a 4-day period comparable to those described here (4). The data from our studies concur with those of Coffin and Blommer (4) and Sherwood et al. (14) which show that mice which appear most likely to succumb to streptococcal pneumonia in its early stages (5 to 6 days) appear to allow rapid proliferation of streptococci with accompanying septicemia, while those that survive hold the bacterial growth in check.
Influenza virus virulence was similar for each pulmonary exposure route, although slightly more virus was required when animals were challenged by i.t. inoculation. One explanation for this discrepancy from the streptococcal model may be the mechanism of pathogenesis of influenza viruses. Influenza virus preferentially replicates in ciliated epithelial cells of the upper respiratory tract, although infections of the lower respiratory tract do occur (15, 16) . The fact that the majority of the i.t. inoculum bypasses the upper respiratory tract and is deposited in the lower respiratory tract, where few influenza infectious sites are located, is indicated by the increased recovery of infectious virus from the lung immediately after i.t. inoculation ( Table 2) .
Administration of an LD50 is dependent upon appropriate calculation of the infectious dose, reproducible administration of the calculated dose, and continued virulence of the infectious agent. In these studies a wide disparity in establishing an influenza virus LD50 was observed. Samples of the same stock of virus were used in all viral experiments to reduce virulence fluctuations. The procedures for viral administration were the same as for streptococcal challenge, and deposition rates should also have been similar. Samples obtained immediately after dosing failed to confirm this, probably due to inability to rescue infecting virus. Therefore, the apparent reason for the observed deviation in calculated versus observed LD50 was the inability to assess the viral concentration accurately at the time of dosing. Influenza replication and virulence were similar for i.n.-, i.t.-, and aerosol-challenged mice in these studies. In previous studies with mice (12) as well as squirrel monkeys (15) , influenza virus deposition and infection following i.n. and small-particle aerosol challenge were also found to be similar.
These data show that mice are as susceptible to S. zooepidemicus or influenza virus infection following i.t. or i.n. instillation as, or more so than, mice infected by aerosol inhalation. This suggests that administration of microbial 
